Institutional investors hold a majority ownership of LLY through the 66.95% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2018, these large investors purchased a net $17.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 3.7 Million shares of Eli Lilly and Co
COLUMBIA MANAGEMENT INVESTMENT A... Bought 2.5 Million shares of Eli Lilly and Co
SCHRODER INVESTMENT MANAGEMENT L... Bought 2.3 Million shares of Eli Lilly and Co